Literature DB >> 23797668

Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites.

Ervin E Kara1, Iain Comerford, Cameron R Bastow, Kevin A Fenix, Wendel Litchfield, Tracy M Handel, Shaun R McColl.   

Abstract

Migration of Th cells to peripheral sites of inflammation is essential for execution of their effector function. The recently described Th9 subset characteristically produces IL-9 and has been implicated in both allergy and autoimmunity. Despite this, the migratory properties of Th9 cells remain enigmatic. In this study, we examined chemokine receptor usage by Th9 cells and demonstrate, in models of allergy and autoimmunity, that these cells express functional CCR3, CCR6, and CXCR3, chemokine receptors commonly associated with other, functionally opposed effector Th subsets. Most Th9 cells that express CCR3 also express CXCR3 and CCR6, and expression of these receptors appears to account for the recruitment of Th9 cells to disparate inflammatory sites. During allergic inflammation, Th9 cells use CCR3 and CCR6, but not CXCR3, to home to the peritoneal cavity, whereas Th9 homing to the CNS during experimental autoimmune encephalomyelitis involves CXCR3 and CCR6 but not CCR3. To our knowledge, these data provide the first insights into regulation of Th9 cell trafficking in allergy and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23797668      PMCID: PMC3721028          DOI: 10.4049/jimmunol.1203089

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response.

Authors:  Adrian Liston; Rachel E Kohler; Scott Townley; Sarah Haylock-Jacobs; Iain Comerford; Adriana C Caon; Julie Webster; Jodie M Harrison; Jeremy Swann; Ian Clark-Lewis; Heinrich Korner; Shaun R McColl
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

2.  Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells.

Authors:  Valérie Staudt; Evita Bothur; Matthias Klein; Karen Lingnau; Sebastian Reuter; Nadine Grebe; Bastian Gerlitzki; Markus Hoffmann; Alexander Ulges; Christian Taube; Nina Dehzad; Marc Becker; Michael Stassen; Andrea Steinborn; Michael Lohoff; Hansjörg Schild; Edgar Schmitt; Tobias Bopp
Journal:  Immunity       Date:  2010-07-30       Impact factor: 31.745

3.  Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population.

Authors:  Hongmei Li; Bardia Nourbakhsh; Bogoljub Ciric; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2010-08-30       Impact factor: 5.422

4.  IL-9 as a mediator of Th17-driven inflammatory disease.

Authors:  Elizabeth C Nowak; Casey T Weaver; Henrietta Turner; Sakhina Begum-Haque; Burkhard Becher; Bettina Schreiner; Anthony J Coyle; Lloyd H Kasper; Randolph J Noelle
Journal:  J Exp Med       Date:  2009-07-13       Impact factor: 14.307

5.  Regulation of IL-9 expression by IL-25 signaling.

Authors:  Pornpimon Angkasekwinai; Seon Hee Chang; Manoj Thapa; Hiroshi Watarai; Chen Dong
Journal:  Nat Immunol       Date:  2010-02-14       Impact factor: 25.606

6.  Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.

Authors:  Anneli Jäger; Valérie Dardalhon; Raymond A Sobel; Estelle Bettelli; Vijay K Kuchroo
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

7.  Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

Authors:  Marc Veldhoen; Catherine Uyttenhove; Jacques van Snick; Helena Helmby; Astrid Westendorf; Jan Buer; Bruno Martin; Christoph Wilhelm; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2008-10-19       Impact factor: 25.606

8.  IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.

Authors:  Jonathan S Dodd; Eda Lum; John Goulding; Roshell Muir; Jacques Van Snick; Peter J M Openshaw
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

9.  The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation.

Authors:  Hua-Chen Chang; Sarita Sehra; Ritobrata Goswami; Weiguo Yao; Qing Yu; Gretta L Stritesky; Rukhsana Jabeen; Carl McKinley; Ayele-Nati Ahyi; Ling Han; Evelyn T Nguyen; Michael J Robertson; Narayanan B Perumal; Robert S Tepper; Stephen L Nutt; Mark H Kaplan
Journal:  Nat Immunol       Date:  2010-05-02       Impact factor: 25.606

10.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

View more
  21 in total

Review 1.  IL-9 and Th9 cells in health and diseases-From tolerance to immunopathology.

Authors:  Junhui Li; Shuqiu Chen; Xiang Xiao; Yong Zhao; Wenjun Ding; Xian C Li
Journal:  Cytokine Growth Factor Rev       Date:  2017-07-17       Impact factor: 7.638

Review 2.  The development and in vivo function of T helper 9 cells.

Authors:  Mark H Kaplan; Matthew M Hufford; Matthew R Olson
Journal:  Nat Rev Immunol       Date:  2015-04-07       Impact factor: 53.106

Review 3.  Th9 and other IL-9-producing cells in allergic asthma.

Authors:  Sonja Koch; Nina Sopel; Susetta Finotto
Journal:  Semin Immunopathol       Date:  2016-11-17       Impact factor: 9.623

4.  Oligodendroglial connexin 47 regulates neuroinflammation upon autoimmune demyelination in a novel mouse model of multiple sclerosis.

Authors:  Yinan Zhao; Ryo Yamasaki; Hiroo Yamaguchi; Satoshi Nagata; Hayato Une; Yiwen Cui; Katsuhisa Masaki; Yuko Nakamuta; Kyoko Iinuma; Mitsuru Watanabe; Takuya Matsushita; Noriko Isobe; Jun-Ichi Kira
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-13       Impact factor: 11.205

5.  Increased Th9 cells and IL-9 levels accelerate disease progression in experimental atherosclerosis.

Authors:  Qing Li; Tingting Ming; Yuanmin Wang; Shaowei Ding; Chaojie Hu; Cuiping Zhang; Qi Cao; Yiping Wang
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

6.  Alkaline Cytosolic pH and High Sodium Hydrogen Exchanger 1 (NHE1) Activity in Th9 Cells.

Authors:  Yogesh Singh; Yuetao Zhou; Xiaolong Shi; Shaqiu Zhang; Anja T Umbach; Madhuri S Salker; Karl S Lang; Florian Lang
Journal:  J Biol Chem       Date:  2016-09-14       Impact factor: 5.157

7.  IL-9-producing Th9 cells may participate in pathogenesis of Takayasu's arteritis.

Authors:  Li-Li Pan; Juan Du; Na Gao; Hua Liao; Jin Wan; Wei-Ping Ci; Chun Yang; Tian Wang
Journal:  Clin Rheumatol       Date:  2016-09-15       Impact factor: 2.980

8.  The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells.

Authors:  Frédérique Végran; Hélène Berger; Romain Boidot; Grégoire Mignot; Mélanie Bruchard; Magalie Dosset; Fanny Chalmin; Cédric Rébé; Valentin Dérangère; Bernhard Ryffel; Masashi Kato; Armelle Prévost-Blondel; François Ghiringhelli; Lionel Apetoh
Journal:  Nat Immunol       Date:  2014-06-29       Impact factor: 25.606

Review 9.  IL-9-producing T cells: potential players in allergy and cancer.

Authors:  Pornpimon Angkasekwinai; Chen Dong
Journal:  Nat Rev Immunol       Date:  2020-08-12       Impact factor: 53.106

Review 10.  Tailored immune responses: novel effector helper T cell subsets in protective immunity.

Authors:  Ervin E Kara; Iain Comerford; Kevin A Fenix; Cameron R Bastow; Carly E Gregor; Duncan R McKenzie; Shaun R McColl
Journal:  PLoS Pathog       Date:  2014-02-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.